Odontogenic Tumors

Odontogenic tumours are neoplasms and tumour-like lesions derived from the tissues that form teeth. They are uncommon, biologically diverse, and range from hamartomatous lesions such as odontomas through locally aggressive benign neoplasms such as ameloblastoma to rare malignant odontogenic carcinomas and sarcomas.

Definition

Odontogenic tumours are a heterogeneous group of neoplasms and hamartomas arising from odontogenic epithelium, odontogenic ectomesenchyme, or both, classified by tissue of origin and biological behaviour under the WHO scheme.

Scope

This topic covers the origin of odontogenic tumours from epithelial, ectomesenchymal, or mixed tooth-forming tissues, the principal benign entities (notably ameloblastoma and odontoma), the concept of local aggressiveness without metastasis, and how the WHO classification organises these lesions. It is a reference overview of classification and biological behaviour, not a guide to surgical management.

Core questions

• From which tooth-forming tissues — epithelial, ectomesenchymal, or mixed — does a given odontogenic tumour arise?
• How are odontogenic tumours classified, and how does the WHO scheme separate benign from malignant entities?
• What does 'locally aggressive but non-metastasising' mean for a benign tumour such as ameloblastoma?
• How are odontogenic tumours distinguished from odontogenic cysts and from non-odontogenic jaw tumours?

Key concepts

• Epithelial, mesenchymal, and mixed odontogenic tumours
• Hamartoma versus true neoplasm
• Ameloblastoma
• Odontoma
• Local aggressiveness without metastasis
• Benign versus malignant odontogenic tumours
• WHO classification of odontogenic tumours

Mechanisms

Odontogenic tumours recapitulate, in disordered form, the epithelial-ectomesenchymal interactions of tooth development. Tumours are grouped by their predominant tissue: epithelial tumours (such as ameloblastoma) arise from odontogenic epithelium; mesenchymal tumours from odontogenic ectomesenchyme; and mixed tumours (such as odontoma) contain both, often producing hard dental tissues. Many behave as benign hamartomas, while neoplasms such as ameloblastoma can infiltrate adjacent bone locally. Molecular studies have identified recurrent alterations — for example, BRAF V600E mutations reported in a substantial proportion of conventional ameloblastomas — that are increasingly incorporated into classification.

Clinical relevance

Because odontogenic tumours span a wide spectrum of behaviour — from inert odontomas to locally infiltrative ameloblastomas and rare malignancies — accurate histological classification is central to understanding their expected course. This entry summarises how these tumours are categorised and recognised and is intended as a reference rather than as individualised clinical guidance.

Epidemiology

Odontogenic tumours are rare relative to odontogenic cysts. In many reported series odontoma is the most frequently encountered odontogenic tumour and ameloblastoma is the most common clinically significant neoplasm, though relative frequencies vary by population and by whether hamartomatous odontomas are included.

Evidence & guidelines

Classification follows the WHO Classification of Head and Neck Tumours. The 4th edition (Wright & Vered, 2017) revised the grouping and nomenclature of odontogenic tumours and simplified the ameloblastoma subtypes, and the 5th edition (Vered & Wright, 2022) further updated entities and incorporated molecular findings. Earlier WHO volumes (Barnes et al., 2005) and reference texts (Neville et al., 2016) provide descriptive background.

History

The nomenclature of odontogenic tumours has changed substantially across WHO editions, including the 2005 reclassification of the keratocyst as a tumour and its later reversal, the consolidation of ameloblastoma variants, and the progressive incorporation of molecular data, reflecting a shift from purely descriptive histology toward a histomolecular framework.

Debates

How should molecular findings reshape odontogenic tumour classification?

Recurrent molecular alterations such as BRAF V600E in ameloblastoma have prompted debate over how far classification and diagnosis should integrate genetic data alongside traditional histology, a direction reflected in successive WHO updates.

Seminal works

• wright-vered-2017
• vered-wright-2022

Frequently asked questions

Are odontogenic tumours cancers?

Most are benign. The group includes hamartomas (such as odontomas) and benign neoplasms (such as ameloblastoma, which can be locally aggressive but does not usually metastasise); malignant odontogenic tumours exist but are rare.

What is the most common odontogenic tumour?

When hamartomatous lesions are included, the odontoma is often reported as the most common; among clinically significant neoplasms, the ameloblastoma is the most frequently encountered.